HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING VIDEO EDUCATION SERVICES
Quote:
Login Free Membership
Search:

Aggressive Growth

Applied Signal Technology, Inc.

Share
July 20, 2009 | Comment(s): 0
Recommended this article (0)
APSG | JAS | BCOM | PWRD
Applied Signal Technology, Inc. (APSG) is up sharply since its original feature as an aggressive growth Zacks Rank Buy in April.

Shares are indeed up for the industrial and defense communications company, but volatility is rampant. APSG was trading near $20, but has since set a new 52-week high and is trading in the mid-$20 range.

Surprises Continue

On June 2nd Applied Signal released its second-quarter results and once again beat analysts' expectations. Net income was $4.1 million, more than double the same period one year ago. Earnings per share came in at 31 cents, easily topping the consensus of just 20 cents.

The quarter was driven by an 18% boost in revenues, up to $53.5 million. It was the company's third consecutive earnings surprise.

Analysts React

Following the report the consensus for fiscal 2009 and 2010 jumped immediately. The average estimate for this year is $1.09, up 19 cents since the report. Next year's consensus is $1.17, an 18 cent climb.

Given these projections year-over-year growth would 73% and 7%, respectively.

The Chart

Shares of APSG have filled the gap created by the strong quarterly report and rebounded quickly. Now that the stock is back in the range set immediately after the earnings number, that $24 level should act as support. Take a look below.

Read the April 21st Feature Here

Last Week's Aggressive Growth Zacks Rank Buy Stocks

Jo-Ann Stores, Inc. (JAS) is expected to grow 30% over each of the next two years and recently topped analyst estimates. Read Full Article.

Perfect World Co., Ltd (PWLD) continues to gain after a great quarter and recently raising guidance. Read Full Article.

012 Smile.Communications (SMLC) has crushed Wall Street estimates and analysts are expecting huge growth rates to continue. Read Full Article.

Noven Pharmaceuticals, Inc. (NOVN) is coming off of a great quarterly report in which revenues were up 29% and resulted in another earnings surprise.

Read Full Article.

Read the full analyst report on APSG

Read the full analyst report on JAS

Read the full analyst report on BCOM

Read the full analyst report on PWRD

 

Please login to Zacks.com or register to post a comment.


Email

Print

Share

Rate Pos

Rate Neg
Attn. Zacks.com Visitors
Sell These Stocks Today
Make sure no Zacks #5 Rank "Strong Sell" stocks are lurking in your portfolio. They tend to perform only 1/6th as well as the market!
Get your free Welcome Gifts today*:
 1.  Zacks "Strong Sell" list.
 2.  Our e-newsletter with 4 "Strong Buy" stocks, Bull & Bear of the Day, and market commentary in every issue.
Get them free right now
  
No cost. Unsubscribe anytime. Privacy Policy
*Only for non-members. May end at any time.

More Zacks Resources

Market Summary May 21, 2012 08:50 am ET
DJIA 12381.57  12.19 0.10%
NASD 2786.92  8.13 0.29%
S&P 500 1298.94  3.72 0.29%
Partner Center